Principles of Cost-Benefit Analysis, Cost-Utility Analysis, CEA, Cost-Consequences Analysis and Cost Analysis; techniques of CBA in health and health care; techniques of CUA and CEA in health and health care; techniques of CCA and CA in health and health care; decision theoretical approaches; pharmacoeco- nomics; economic evaluation of clinical devices; economic evaluation of public health interventions; outcome measures and their interpretation; evidence, efficacy and effectiveness; Health Technology Assessment; study design; risk and uncer- tainty; discounting; sensitivity analyses; modeling; systematic reviews and meta-analyses.
An introduction to the work of Edgar Sydenstricker, a forgotten health economist who researched the 1918-20 influenza pandemic, the Great Depression, and inequalities in the impact of diseases such as pellagra.
Today marks World Tuberculosis (TB) Day – a celebration of the anniversary of Robert Koch’s announcement that he had discovered the Mycobacterium tuberculosis (MTB) bacteria, which causes the disease. Today, 139 years after this announcement and in the context of… Read More »World TB Day 2021: the latest economics research
In our first post, we explained opportunity cost, marginal productivity (of a healthcare system), net benefit, and cost-effectiveness threshold. In this post, we put forward our views on how to use cost-effectiveness thresholds and the existing estimates of marginal productivity… Read More »Opportunity costs, marginal productivity, and cost-effectiveness thresholds: providing useful analysis and communicating results
In this post, we explain key concepts of cost-effectiveness analysis in healthcare and how they are linked: opportunity cost, marginal productivity (of a healthcare system), net benefit, and cost-effectiveness threshold. In another post, to be published tomorrow, we will propose… Read More »Opportunity costs, marginal productivity, and cost-effectiveness thresholds: what are they and how are they related?
On the third Thursday of every month, we speak to a recent graduate about their thesis and their studies. This month’s guest is Dr Chris Sampson who has a PhD from the University of Nottingham. If you would like to… Read More »Thesis Thursday: Chris Sampson
From time to time, a little puff of steam emerges from my Twitter feed as Paul Kind (one of the founding members of the EuroQol Group and a key figure in the development of the EQ-5D) objects to yet another… Read More »‘Preference-based measure’ is misleading – can we agree on something better?
On the third Thursday of every month, we speak to a recent graduate about their thesis and their studies. This month’s guest is Dr Christopher Yau who has a PhD from the University of Bristol. If you would like to… Read More »Thesis Thursday: Christopher Yau
A few weeks ago, NICE published its ‘updated principles‘ – a guide to what the Institute takes into account when developing its guidance, and to the “morals, ethics and values” that underpin its recommendations. This follows a public consultation in… Read More »Some reflections on the new NICE Principles
As many of us who have had to review submitted journal articles, thesis defenses, grant applications, white papers, and even published literature know, providing feedback on something that is poorly conceived is much harder than providing feedback on something well… Read More »Are QALYs #ableist?
Non-health economists (henceforth referred to as ‘lay stakeholders’) are often asked to use the outputs of cost-effectiveness models to inform decisions, but they can find them difficult to understand. Conversely, health economists may have limited experience of explaining cost-effectiveness models… Read More »How to explain cost-effectiveness models for diagnostic tests to a lay audience